ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA facial FPS 15

Product NDC: 13537-199
11-digit product format: 135370199
Labeler code: 13537
Product ID: 13537-199_d8c0d739-fedf-497c-9967-21bd5b57f772
Type: HUMAN OTC DRUG
Nonproprietary name: Octinoxate and Oxybenzone
Dosage form: CREAM
Route: TOPICAL
Labeler: Ventura Corporation LTD
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2014-02-20
Marketing end: 0000-00-00
Substance: OCTINOXATE; OXYBENZONE
Active strength: 0 g/g; g/g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	13537-199		D	Discontinued by firm		2026-10-05
excluded package	package	13537-199	13537-199-02	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	13537-199-02	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	13537-199-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	13537-199-02	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	13537-199-02	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	13537-199-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	13537-199-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	13537-199-02	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	13537-199-02	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	13537-199-02	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	13537-199-02	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	13537-199-02	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	13537-199-02	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	13537-199-02	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	13537-199-02	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	13537-199-02	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	13537-199-02	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	13537-199-02	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	13537-199-02	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	13537-199-02	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	13537-199-02	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	13537-199-02	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	13537-199-02	I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
13537-199-02	2025-11-05	C162847	48780-1	9855e2a2-43bc-60a7-e053-dbdaa90a05bd	ESIKA NATURAL CARE CONCHA DE NÁCAR & ROSA MOSQUETA crema facial FPS 15
13537-199-02	2019-11-27	C162847	48780-1	9855e2a2-43bc-60a7-e053-dbdaa90a05bd	ESIKA NATURAL CARE CONCHA DE NÁCAR & ROSA MOSQUETA crema facial FPS 15

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Octinoxate	ACTIVE INGREDIENT	4Y5P7MUD51	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
Oxybenzone	ACTIVE INGREDIENT	95OOS7VE0Y	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
Octinoxate	ACTIVE MOIETY	4Y5P7MUD51	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
Oxybenzone	ACTIVE MOIETY	95OOS7VE0Y	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ALANINE	INACTIVE INGREDIENT	OF5P57N2ZX	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ARCTOSTAPHYLOS UVA-URSI LEAF	INACTIVE INGREDIENT	3M5V3D1X36	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CALCIUM PANTOTHENATE	INACTIVE INGREDIENT	568ET80C3D	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CASTORYL MALEATE	INACTIVE INGREDIENT	V5B97ZYP2F	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
CYCLOMETHICONE 6	INACTIVE INGREDIENT	XHK3U310BA	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
DICAPRYLYL CARBONATE	INACTIVE INGREDIENT	609A3V1SUA	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
EDETATE SODIUM	INACTIVE INGREDIENT	MP1J8420LU	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ISOBUTYLPARABEN	INACTIVE INGREDIENT	0QQJ25X58G	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
MAGNESIUM CHLORIDE	INACTIVE INGREDIENT	02F3473H9O	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
MAGNESIUM LACTATE	INACTIVE INGREDIENT	MT6QI8324A	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PAPAIN	INACTIVE INGREDIENT	A236A06Y32	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
POTASSIUM LACTATE	INACTIVE INGREDIENT	87V1KMK4QV	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PROLINE	INACTIVE INGREDIENT	9DLQ4CIU6V	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
ROSA MOSCHATA SEED OIL	INACTIVE INGREDIENT	T031ZE559T	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
SERINE	INACTIVE INGREDIENT	452VLY9402	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
SODIUM LACTATE	INACTIVE INGREDIENT	TU7HW0W0QT	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
UREA	INACTIVE INGREDIENT	8W8T17847W	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
13537-199	ESIKA NATURAL CARE CONCHA DE NACAR AND ROSA MOSQUETA FACIAL FPS 15 (OCTINOXATE AND OXYBENZONE) CREAM [VENTURA CORPORATION LTD]	1	Legacy NDC	20140306_2bc3e4f1-89ab-491f-8f79-7faaca82bb18.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
95OOS7VE0Y	OXYBENZONE	131-57-7	OXYBENZONE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ESIKA NATURAL CARE CONCHA DE NÁCAR & ROSA MOSQUETA crema facial FPS 15	Ventura Corporation LTD \| Bel Star S.A. (Colombia)	2014-02-19	HUMAN OTC DRUG LABEL	1